Startups
Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.”
Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success.
Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients.
Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success.
Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients.
Overview
Location
United States, California, Santa Clara
Employees
11-50
Founded date
2014
FAQ about Seed Therapeutics
When was Seed Therapeutics founded?
Seed Therapeutics was founded in 2014.
Is Seed Therapeutics still active?
Yes, Seed Therapeutics is active; its latest activity on Parsers VC dates from Oct 3, 2015.